Padcev Sales Exceed Expectations As Seattle Genetics Pursues Earlier Indications

Hitting bigger business target
Analysts raised their Padcev forecasts based on Q1 sales
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip